Loss of effector function of human cytolytic T lymphocytes is accompanied by major alterations in N- and O-glycosylation.

The Journal of Biological Chemistry
Aristotelis AntonopoulosAnne Dell

Abstract

Most human tumors are not eliminated by the immune system, and therapeutic vaccination shows poor results, a fact that can be explained at least partially by an immunosuppressive tumor microenvironment that is abundant in galectin-3. On cytolytic T lymphocyte (CTL) clones, maintained in culture by regular stimulation, recently activated CTLs present low effector functions. However, these functions are restored after a short treatment with LacNAc. The latter, which is in agreement with the glycoprotein-galectin lattice concept involving reduced motility, poses the question why galectin-3 ligands improve effector functions. We employed ultrasensitive MALDI-TOF-MS on resting and recently activated CTL clones combined with various glycosidase digestions and GC-MS linkage analyses. Our results showed that compared with the resting CTLs, the N-glycans of the recently activated CTLs consisted of (i) larger LacNAc oligomers of which a significant portion was longer than four-units and (ii) more multi-antennary structures. Interestingly, our results showed that the poly-LacNAc appeared to be equally distributed on all available N-glycan branches and not selectively enriched on a specific branch. The above structural alterations in the r...Continue Reading

References

May 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·E K BarberC E Rudd
Jan 1, 1988·Annual Review of Immunology·H CleversC Terhorst
Sep 12, 2002·Biochimica Et Biophysica Acta·Jun HirabayashiKen-ichi Kasai
Dec 3, 2002·The Journal of Biological Chemistry·Anne Marie MoodyEllis L Reinherz
Apr 5, 2003·The Journal of Biological Chemistry·Anthony H MerrySimon J Davis
Jan 5, 2005·Nature Reviews. Cancer·Fu-Tong Liu, Gabriel A Rabinovich
Jul 7, 2005·Nature Reviews. Immunology·Peter FriedlMatthias Gunzer
Feb 10, 2006·Cancer Immunology, Immunotherapy : CII·Helena HarlinThomas F Gajewski
Mar 23, 2006·Annual Review of Immunology·Thierry BoonPierre van der Bruggen
Aug 5, 2006·The Journal of Immunology : Official Journal of the American Association of Immunologists·Elena M ComelliJames C Paulson
Sep 25, 2007·Proceedings of the National Academy of Sciences of the United States of America·Akira TogayachiHisashi Narimatsu
Jan 25, 2008·The Journal of Biological Chemistry·Sean R StowellRichard D Cummings
Mar 4, 2008·Journal of Proteome Research·Alessio CeroniStuart M Haslam
Jan 28, 2009·The Journal of Experimental Medicine·Jürgen KuballPhilip D Greenberg
Apr 15, 2009·Nature Reviews. Immunology·Gabriel A Rabinovich, Marta A Toscano
Nov 19, 2009·The Journal of Biological Chemistry·Lesley A EarlLinda G Baum
Sep 23, 2011·Biochemical Society Transactions·Aristotelis AntonopoulosAnne Dell

❮ Previous
Next ❯

Citations

Mar 15, 2013·Trends in Immunology·Jenny L JohnsonBrian A Cobb
Feb 5, 2013·Molecular & Cellular Proteomics : MCP·James W Dennis, C Fred Brewer
Mar 27, 2012·Immunity·Gabriel A Rabinovich, Diego O Croci
Sep 8, 2016·The Tohoku Journal of Experimental Medicine·Edgar Ramos-MartínezFrancisco Blanco-Favela
Mar 8, 2019·Interface Focus·Hannah J Lomax-BrowneMiriam V Dwek
Aug 19, 2018·Nature Communications·N GiovannoneC J Dimitroff
Aug 24, 2018·Nature Communications·Jenna Geddes SweeneyCharles J Dimitroff
Jan 11, 2019·International Journal of Molecular Sciences·Guillaume PoirouxHervé Benoist
Feb 15, 2014·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Nathalie DemottePierre van der Bruggen
Apr 24, 2020·Molecular Cell·Benjamin SchumannCarolyn Ruth Bertozzi

❮ Previous
Next ❯

Related Concepts

Related Feeds

ASBMB Publications

The American Society for Biochemistry and Molecular Biology (ASBMB) includes the Journal of Biological Chemistry, Molecular & Cellular Proteomics, and the Journal of Lipid Research. Discover the latest research from ASBMB here.